NASDAQ
Inhibrx Biosciences Inc. (INBX) has a fcf yield of -10.61% as of Monday, August 3, 2026. This represents a 63.43% increase compared to its 12-month average of -29.01%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.